Universal face masking reduces endophthalmitis incidence during anti-VEGF injections
Dr Sunir J. Garg speaks on the influence of COVID-19 universal face masking on the risk of endophthalmitis following intravitreal anti-VEGF injections.
Ophthalmology Times Europe's Sheryl Stevenson speaks with Dr Sunir J. Garg, co-director of retina research at the Wills Eye Hospital in Baltimore, Maryland, United States, on the highlights of his presentation at the 2021 annual American Academy of Ophthalmology (AAO) meeting regarding the impact of COVID-19 universal face masking on the risk of endophthalmitis following intravitreal anti-vascular endothelial growth factor (VEGF) injections.
The American Academy of Ophthalmology (AAO) annual meeting was held November 12 to 15 at the Ernest N. Morial Convention Centre in New Orleans, Louisiana, United States. The event included Subspecialty Days and a virtual component for remote participation.
Related Content: Additional AAO content | Retina | Inflammation & Infection
Newsletter
Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.
